Cargando…

Sulfamethoxazole/Trimethoprim induced liver failure: a case report

Sulfamethoxazole/Trimethoprim (SMX/TMP) is a commonly used antibiotic, its' known adverse reaction of hepatotoxicity leading to acute liver failure is considered rare. We present a case of a 22 year old female who developed jaundice and acute liver failure one week after taking SMX/TMP for a UT...

Descripción completa

Detalles Bibliográficos
Autores principales: Abusin, Salaheldin, Johnson, Swapna
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490670/
https://www.ncbi.nlm.nih.gov/pubmed/18637204
http://dx.doi.org/10.1186/1757-1626-1-44
_version_ 1782158132006354944
author Abusin, Salaheldin
Johnson, Swapna
author_facet Abusin, Salaheldin
Johnson, Swapna
author_sort Abusin, Salaheldin
collection PubMed
description Sulfamethoxazole/Trimethoprim (SMX/TMP) is a commonly used antibiotic, its' known adverse reaction of hepatotoxicity leading to acute liver failure is considered rare. We present a case of a 22 year old female who developed jaundice and acute liver failure one week after taking SMX/TMP for a UTI. After an extensive work up, a clinical diagnosis of SMX/TMP induced liver failure was reached. Over the course of several weeks she made a good clinical and biochemical recovery with supportive care. In this case report we describe her clinical presentation and course, and present a brief review of the literature.
format Text
id pubmed-2490670
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24906702008-07-30 Sulfamethoxazole/Trimethoprim induced liver failure: a case report Abusin, Salaheldin Johnson, Swapna Cases J Case Report Sulfamethoxazole/Trimethoprim (SMX/TMP) is a commonly used antibiotic, its' known adverse reaction of hepatotoxicity leading to acute liver failure is considered rare. We present a case of a 22 year old female who developed jaundice and acute liver failure one week after taking SMX/TMP for a UTI. After an extensive work up, a clinical diagnosis of SMX/TMP induced liver failure was reached. Over the course of several weeks she made a good clinical and biochemical recovery with supportive care. In this case report we describe her clinical presentation and course, and present a brief review of the literature. BioMed Central 2008-07-18 /pmc/articles/PMC2490670/ /pubmed/18637204 http://dx.doi.org/10.1186/1757-1626-1-44 Text en Copyright © 2008 Abusin and Johnson; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Abusin, Salaheldin
Johnson, Swapna
Sulfamethoxazole/Trimethoprim induced liver failure: a case report
title Sulfamethoxazole/Trimethoprim induced liver failure: a case report
title_full Sulfamethoxazole/Trimethoprim induced liver failure: a case report
title_fullStr Sulfamethoxazole/Trimethoprim induced liver failure: a case report
title_full_unstemmed Sulfamethoxazole/Trimethoprim induced liver failure: a case report
title_short Sulfamethoxazole/Trimethoprim induced liver failure: a case report
title_sort sulfamethoxazole/trimethoprim induced liver failure: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490670/
https://www.ncbi.nlm.nih.gov/pubmed/18637204
http://dx.doi.org/10.1186/1757-1626-1-44
work_keys_str_mv AT abusinsalaheldin sulfamethoxazoletrimethopriminducedliverfailureacasereport
AT johnsonswapna sulfamethoxazoletrimethopriminducedliverfailureacasereport